Hobyung Chung Selected Research

Neoplasms (Cancer)

9/2012	Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
1/2011	Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma.
7/2010	Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma.
7/2010	Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
5/2010	Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience.
8/2008	Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
1/2008	Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
1/2008	Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
9/2007	Review of current staging systems for hepatocellular carcinoma.
2/2007	Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hobyung Chung Research Topics

Disease

47	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2002
25	Neoplasms (Cancer) 09/2012 - 01/2003
6	Fibrosis (Cirrhosis) 01/2011 - 12/2005
5	Neoplasm Metastasis (Metastasis) 05/2010 - 12/2002
4	Chronic Hepatitis C 01/2011 - 12/2006
3	Infections 01/2018 - 12/2006
3	Hepatitis C 01/2017 - 12/2006
3	Chronic Hepatitis (Chronic Active Hepatitis) 02/2010 - 12/2005
3	Hepatitis 02/2010 - 01/2003
2	Autoimmune Hepatitis 01/2013 - 02/2010
2	Autoimmune Pancreatitis 01/2013 - 02/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2011 - 12/2006
2	Iron Overload 01/2008 - 12/2006
2	Liver Diseases (Liver Disease) 12/2005 - 01/2003
2	Liver Neoplasms (Liver Cancer) 12/2004 - 01/2003
2	Pleural Effusion (Pleural Effusions) 05/2004 - 01/2003
2	Hemangioma (Angioma) 04/2004 - 12/2002
2	Thrombosis (Thrombus) 01/2003 - 01/2003
1	Proteinuria 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 05/2019
1	Angiomyolipoma 01/2017
1	Gastrinoma 07/2015
1	Pancreatic Diseases (Pancreatic Disease) 01/2013
1	Immunoglobulin G4-Related Disease 01/2013
1	Hypoxia (Hypoxemia) 01/2011
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2010
1	Sclerosing Cholangitis 02/2010
1	Cysts 12/2009
1	Sclerosis 12/2009
1	Polycystic liver disease 12/2009
1	Foreign-Body Granuloma (Granuloma, Foreign Body) 03/2008
1	Residual Neoplasm 01/2008
1	Jaundice (Icterus) 01/2008
1	Hyperferritinemia 12/2006
1	Ascites 02/2006
1	Focal Nodular Hyperplasia 04/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2003
1	Hemochromatosis (Bronze Diabetes) 07/2003
1	Pancytopenia 07/2003

Drug/Important Bio-Agent (IBA)

11	InterferonsIBA 01/2018 - 01/2003
7	SonazoidIBA 01/2017 - 01/2008
6	SHU 508 (Levovist)IBA 07/2010 - 03/2003
6	Coloring Agents (Dyes)IBA 04/2004 - 12/2002
5	Contrast MediaIBA 01/2008 - 06/2003
4	acarboxyprothrombin (PIVKA)IBA 08/2008 - 12/2006
3	Immunoglobulin G (IgG)IBA 05/2019 - 02/2010
2	Sorafenib (BAY 43-9006)FDA Link 12/2015 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 07/2010
2	Fluorouracil (Carac)FDA LinkGeneric 12/2015 - 07/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2013 - 02/2010
2	AutoantibodiesIBA 01/2013 - 02/2010
2	GadoliniumIBA 09/2012 - 01/2011
2	gadolinium ethoxybenzyl DTPA FDA Link 09/2012 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 01/2008
2	Ribavirin (Virazole)FDA LinkGeneric 01/2011 - 01/2010
2	Ferritins (Ferritin)IBA 01/2010 - 12/2006
2	Alanine Transaminase (SGPT)IBA 01/2010 - 01/2008
2	Tumor Biomarkers (Tumor Markers)IBA 08/2008 - 07/2008
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2008 - 12/2006
2	ferric oxide (iron oxide)IBA 01/2008 - 12/2005
2	IronIBA 01/2008 - 12/2006
2	Prothrombin (Factor II)IBA 01/2007 - 02/2006
2	Serum AlbuminIBA 01/2007 - 02/2006
1	lenvatinibIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	CalciumIBA 07/2015
1	EnzymesIBA 01/2013
1	Pentetic Acid (DTPA)FDA LinkGeneric 09/2012
1	JNK Mitogen-Activated Protein KinasesIBA 04/2012
1	Pharmaceutical PreparationsIBA 02/2011
1	Branched-Chain Amino AcidsIBA 01/2011
1	CholesterolIBA 01/2011
1	diethylenetriamineIBA 01/2011
1	AlbuminsIBA 01/2011
1	AcidsIBA 01/2011
1	FluorocarbonsIBA 05/2010
1	Ethanol (Ethyl Alcohol)IBA 12/2009
1	ethanolamine oleate (Ethamolin)FDA Link 12/2009
1	lentil lectinIBA 08/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2008
1	Vitamin K FDA Link 01/2007
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2007
1	HepcidinsIBA 12/2006
1	BilirubinIBA 02/2006
1	HemosiderinIBA 07/2003
1	Therapeutic UsesIBA 07/2003

Therapy/Procedure

20	Therapeutics 12/2015 - 01/2003
20	Radiofrequency Ablation 07/2010 - 01/2003
6	Microbubbles 05/2010 - 06/2003
3	Aftercare (After-Treatment) 09/2003 - 03/2003
2	Drug Therapy (Chemotherapy) 12/2015 - 07/2010
2	Surgical Instruments (Clip) 12/2004 - 01/2003
2	Intravenous Injections 09/2003 - 03/2003
1	Sclerotherapy 12/2009
1	Catheters 12/2009
1	Hepatectomy 08/2008
1	Liver Transplantation 01/2007
1	Electrodes (Electrode) 07/2004
1	Erythrocyte Transfusion 07/2003